Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1.
Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1.
复制标题
DOI:
10.1038/s41467-023-44504-4
复制
发表时间:
2024-01-02
影响因子:
16.6
通讯作者:
Zheng, Yong-Hui
中科院分区:
文献类型:
--
作者:
Khan, Ilyas;Li, Sunan;Tao, Lihong;Wang, Chong;Ye, Bowei;Li, Huiyu;Liu, Xiaoyang;Ahmad, Iqbal;Su, Wenqiang;Zhong, Gongxun;Wen, Zhiyuan;Wang, Jinliang;Hua, Rong-Hong;Ma, Ao;Liang, Jie;Wan, Xiao-Peng;Bu, Zhi-Gao;Zheng, Yong-Hui
SARS-CoV-2 and filovirus enter cells via the cell surface angiotensin-converting enzyme 2 (ACE2) or the late-endosome Niemann-Pick C1 (NPC1) as a receptor. Here, we screened 974 natural compounds and identified Tubeimosides I, II, and III as pan-coronavirus and filovirus entry inhibitors that target NPC1. Using in-silico, biochemical, and genomic approaches, we provide evidence that NPC1 also binds SARS-CoV-2 spike (S) protein on the receptor-binding domain (RBD), which is blocked by Tubeimosides. Importantly, NPC1 strongly promotes productive SARS-CoV-2 entry, which we propose is due to its influence on fusion in late endosomes. The Tubeimosides’ antiviral activity and NPC1 function are further confirmed by infection with SARS-CoV-2 variants of concern (VOC), SARS-CoV, and MERS-CoV. Thus, NPC1 is a critical entry co-factor for highly pathogenic human coronaviruses (HCoVs) in the late endosomes, and Tubeimosides hold promise as a new countermeasure for these HCoVs and filoviruses. How SARS-CoV-2 enters cells and causes COVID-19 is still under intensive investigation. Here, the authors identify unexpected crosstalk between human coronavirus and filovirus entry and discover pan-inhibitors for these highly pathogenic viruses.
登录
查看更多内容
影响因子:
64.8
作者:
Cote, Marceline;Misasi, John;Ren, Tao;Bruchez, Anna;Lee, Kyungae;Filone, Claire Marie;Hensley, Lisa;Li, Qi;Ory, Daniel;Chandran, Kartik;Cunningham, James
通讯作者:
Cunningham, James
影响因子:
64.5
作者:
Daniloski Z;Jordan TX;Wessels HH;Hoagland DA;Kasela S;Legut M;Maniatis S;Mimitou EP;Lu L;Geller E;Danziger O;Rosenberg BR;Phatnani H;Smibert P;Lappalainen T;tenOever BR;Sanjana NE
通讯作者:
Sanjana NE
影响因子:
11.4
作者:
Miller, Emily Happy;Obernosterer, Gregor;Chandran, Kartik
通讯作者:
Chandran, Kartik
影响因子:
6.4
作者:
Basu, Arnab;Mills, Debra M.;Bowlin, Terry L.
通讯作者:
Bowlin, Terry L.
影响因子:
5.8
作者:
Mirdita, Milot;Steinegger, Martin;Soeding, Johannes
通讯作者:
Soeding, Johannes